Satellos Bioscience Inc (MSLE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 26,459 | 20,398 | 12,312 | 6,524 | 4,654 |
| Operating Income | -26,459 | -20,398 | -12,312 | -6,524 | -4,654 |
| Interest Expense | 0 | 0 | 131 | 0 | 41 |
| Other Income | 1,758 | -236 | 673 | -2,181 | -7,677 |
| Pre-tax Income | -24,701 | -20,634 | -11,771 | -8,705 | -12,372 |
| Income Tax | 172 | N/A | N/A | 4 | N/A |
| Net Income Continuous | -24,873 | -20,634 | -11,771 | -8,709 | -12,372 |
| Net Income | $-24,873 | $-20,634 | $-11,771 | $-8,709 | $-12,372 |
| EPS Basic Total Ops | -1.70 | -2.16 | -1.60 | -2.95 | -6.13 |
| EPS Basic Continuous Ops | -1.70 | -2.16 | -1.64 | -2.93 | -6.17 |
| EPS Diluted Total Ops | -1.70 | -2.16 | -1.60 | -2.95 | -6.13 |
| EPS Diluted Continuous Ops | -1.70 | -2.16 | -1.64 | -2.93 | -6.17 |
| EPS Diluted Before Non-Recurring Items | -1.70 | -0.48 | -1.68 | -3.00 | -2.52 |
| EBITDA(a) | $-26,455 | $-17,478 | $-12,307 | $-4,045 | $-4,481 |